(Q30427424)

21 June 2017

title

Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control (English)

1 reference

adaptive radiation therapy

21 June 2017

main subject

0 references

3

Garden AS

1 reference

21 June 2017

6

Morrison WH

1 reference

21 June 2017

7

Peters LJ

1 reference

21 June 2017

5

Ang KK

1 reference

21 June 2017

Sanguineti G

1

1 reference

21 June 2017

Geara FB

series ordinal

2

1 reference

21 June 2017

Tucker SL

series ordinal

4

1 reference

21 June 2017

language of work or name

English

0 references

publication date

1 March 1997

1 reference

21 June 2017

number of pages

12

1 reference

International Journal of Radiation Oncology Biology Physics

inferred from page(s)

published in

1 reference

21 June 2017

volume

37

1 reference

21 June 2017

issue

5

1 reference

21 June 2017

page(s)

985-996

1 reference

Chemo-radiotherapy in patients with locally advanced nasopharyngeal carcinoma: a radiation therapy oncology group study

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Radiation management of advanced nasopharyngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Lymphoepithelioma of the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Nasopharyngeal carcinoma: treatment results with primary radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Analysis of failures after definitive irradiation for epidermoid carcinoma of the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Carcinoma of the nasopharynx: results of radiation treatment and some prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Irradiation of nasopharyngeal carcinoma: correlations with treatment factors and stage

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Regional Stage IV carcinoma of the nasopharynx treated by aggressive radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Adjuvant chemotherapy for advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Patterns of failure in nasopharyngeal cancer treated with megavoltage irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Prognostic factors of carcinoma of the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Does induction chemotherapy have a role in the management of nasopharyngeal carcinoma? Results of treatment in the era of computerized tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Analysis of prognostic factors and proposal of a new classification for nasopharyngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Carcinoma of the nasopharynx. A 25-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Carcinoma of the nasopharynx. Eighteen years' experience with megavoltage radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Carcinoma of the nasopharynx—The significance of histology

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Carcinoma of the nasopharynx: analysis of treatment results in 167 consecutively admitted patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Prognostic factors in patients with nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Nasopharyngeal carcinoma: local control by megavoltage irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Effect of time, dose and fractionation on local control of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Improved dose distributions for 3D conformal boost treatments in carcinoma of the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Malignant tumours of the nasopharynx: retrospective review of 74 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Split-course radiation therapy of carcinoma of the nasopharynx: results of a national collaborative clinical trial of the Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Dose-response analysis for nasopharyngeal carcinoma: an historical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Megavoltage irradiation of epithelial tumors of the nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Carcinoma of the nasopharynx: factors affecting prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Advanced carcinoma of the nasopharynx. 2. Pattern of failure in 256 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Impact of changes in the treatment of nasopharyngeal carcinoma: an experience of 30 years

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Prognosis and histology in Stage I nasopharyngeal carcinoma (NPC).

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Carcinoma of the nasopharynx: survival and patterns of recurrence.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Cranial nerve involvement and base of the skull erosion in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma on local control and short-term survival

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Extent of nasopharyngeal carcinoma involvement inside the nasopharynx. Lack of prognostic value on local control

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Radiotherapy for nasopharyngeal carcinoma: shielding the pituitary may improve therapeutic ratio

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Sequential chemotherapy and radiation for nasopharyngeal cancer: absence of long-term benefit despite a high rate of tumor response to chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

A proposed modification of the Ho stage-classification for nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Prognostic factors in nasopharyngeal carcinoma investigated by computer tomography--an analysis of 659 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

A clinical study of 407 cases of nasopharyngeal carcinoma in Hong Kong

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Carcinoma of the nasopharynx: a review of 86 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Patterns of failure in carcinoma of the nasopharynx: I. Failure at the primary site

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

Management of local residual primary lesion of nasopharyngeal carcinoma (NPC): are higher doses beneficial?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900104-1

7 January 2021

10.1016/S0360-3016(97)00104-1

Identifiers

DOI

1 reference

21 June 2017

1 reference